Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Trichoscopy helps diagnose and monitor alopecia areata by looking at a combination of specific hair and scalp features.

Alopecia areata can be triggered by specific immune cells without genetic or environmental factors.

Guidelines help design better trials to compare alopecia areata treatments.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Other common signs, not just the well-known immune cells around hair bulbs, are important for diagnosing hair loss from alopecia areata.

Apremilast may help treat hair loss in alopecia areata.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

Kids with alopecia areata may experience more stress but not necessarily feel more anxious or depressed than others.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

PUVA treatment led to significant hair regrowth in over half of the patients with alopecia areata totalis and universalis.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Narrowband UVB phototherapy alone is not very effective for treating alopecia areata.

Using minoxidil and anthralin together can improve hair regrowth in severe alopecia areata patients who didn't respond to individual treatments.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Quercetin effectively treated and prevented hair loss in mice.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Methotrexate with corticosteroids can effectively treat severe alopecia areata but often requires long-term maintenance.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Trichoscopy is good for telling apart tinea capitis and alopecia areata in kids.